轮状病毒疫苗接种对印度轮状病毒疾病负担及相关抗生素使用的影响:一项动态基于代理的模拟分析
该研究使用动态基于代理的模型模拟印度五岁以下儿童轮状病毒传播,评估疫苗接种对疾病负担和抗生素滥用的影响。结果显示,疫苗接种使轮状病毒病例患病率降低33.7%(预测区间:30.7-36.0%),相关抗生素滥用减少21.8%(18.6-25.1%),死亡减少38.3%(31.3-44.4%)。结论认为儿童轮状病毒疫苗普遍接种可大幅减少印度不适当抗生素使用。
要点
- 轮状病毒疫苗接种使五岁以下儿童轮状病毒病例患病率降低33.7%(预测区间:30.7-36.0%)。
- 轮状病毒相关抗生素滥用减少21.8%(18.6-25.1%),死亡减少38.3%(31.3-44.4%)。
- 若疫苗接种覆盖率提高50.3%(45.2-58.5%)至全国68.1%(63.1-76.4),轮状病毒患病率预计降至每10万人中不足1例。
核心结论
- 儿童轮状病毒疫苗普遍接种可大幅减少印度不适当抗生素使用。
研究设计与样本
- 研究构建了印度每个地区五岁以下儿童轮状病毒进展的动态基于代理模型,模拟不同疫苗接种覆盖率场景。
- 人群数据来自全国家庭调查,用于校准模型;疾病参数来自已发表研究。
主要发现
- 轮状病毒疫苗接种使五岁以下儿童轮状病毒病例患病率降低33.7%(预测区间:30.7-36.0%)。
- 轮状病毒疫苗接种使轮状病毒相关总抗生素滥用减少21.8%(18.6-25.1%)。
- 轮状病毒疫苗接种使轮状病毒相关总死亡减少38.3%(31.3-44.4%)。
- 轮状病毒感染相关抗生素滥用占总抗生素消耗的7.6%(7.5-7.9%),而无疫苗接种时为9.6%(9.4-9.9%)。
- 若全国疫苗接种覆盖率提高50.3%(45.2-58.5%)至68.1%(63.1-76.4),预计轮状病毒患病率降至每10万人中不足1例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Rotavirus is a leading cause of diarrhea in infants and young children in many low- and middle-income countries. India launched a childhood immunization program for rotavirus in 2016, starting with four states and expanding it to cover all states by 2019. The objective of this study was to estimate the effects of the rotavirus vaccination program in India on disease burden and antibiotic misuse. METHODS: We built a dynamic agent-based model of rotavirus progression in children under five within each district in India. Simulations were run for various scenarios of vaccination coverage in the context of India's Universal Immunization Programme. Population data were obtained from the National Family Household Surveys and used to calibrate the models. Disease parameters were obtained from published studies. We estimated past and projected future reduction of disease burden and antibiotic misuse due to full vaccination nationwide, by state, and by wealth quintile. RESULTS: We estimate that rotavirus vaccination in India has reduced the prevalence of rotavirus cases by 33.7% (prediction interval: 30.7-36.0%), total antibiotic misuse due to rotavirus by 21.8% (18.6-25.1%), and total deaths due to rotavirus by 38.3% (31.3-44.4%) for children under five. We estimate total antibiotic misuse due to rotavirus infection to be 7.6% (7.5-7.9%) of total antibiotic consumption in this demographic versus 9.6% (9.4-9.9%) in the absence of vaccination. We project rotaviral prevalence to drop to below one case for every 100,000 individuals in those below five if vaccination coverage is increased by 50.3% (45.2-58.5%) to 68.1% (63.1-76.4) nationwide. CONCLUSION: Universal coverage of childhood rotavirus vaccination can substantially reduce inappropriate antibiotic use in India.
引用
- Gleason A, Kumar CK, Klein E, et al. Effect of rotavirus vaccination on the burden of rotavirus disease and associated antibiotic use in India: A dynamic agent-based simulation analysis. Vaccine. 2024. PMID: 39137492. doi:10.1016/j.vaccine.2024.126211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。